Filing Details
- Accession Number:
- 0001209191-17-052893
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-14 21:21:09
- Reporting Period:
- 2017-09-12
- Accepted Time:
- 2017-09-14 21:21:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1435049 | Aduro Biotech Inc. | ADRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1465994 | Jennifer Lew | C/O Aduro Biotech, Inc. 740 Heinz Avenue Berkeley CA 94710 | Sr. Vice President Of Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-12 | 23,300 | $0.00 | 65,895 | No | 4 | A | Direct | |
Common Stock | Disposition | 2017-09-13 | 3,557 | $10.99 | 62,338 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2017.
- The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.